Injectable semaglutide (Ozempic) reduces HbA1c levels by 1.4%1.6% at week 30, again depending on the dosage strength
34 Liraglutide is a glucagon-like peptide-1 receptor agonist that is administered subcutaneously and leads to weight loss when used for diabetes
Even with their significant potential benefits, however, GLP-1 RAs come with safety warnings for patients to speak with their doctor before starting treatment if they have a history of diabetic retinopathy
The difference between a well-run 503B outsourcing facility and a poorly managed 503A pharmacy can be the difference between a safe, effective product and one that carries real risks
Declining estrogen triggers insulin resistance, muscle loss, and abdominal fat storage, which is why diet and exercise alone often stop working in your 40s
- We should be jubilant about a safe, effective class of drugs to address obesity